ClinicalTrials.gov
ClinicalTrials.gov Menu

Risk Reduction for Drug Use and Sexual Revictimization (RRFT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00998153
Recruitment Status : Completed
First Posted : October 20, 2009
Last Update Posted : June 18, 2018
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Medical University of South Carolina

Brief Summary:
The investigator proposes to evaluate Risk Reduction through Family Therapy (RRFT), which integrates: 1) an ecologically-based intervention for treatment of substance abuse behaviors in high risk adolescents, 2) exposure-based cognitive-behavioral therapy for sexually assaulted youth, and 3) psychoeducation strategies for prevention of risky sexual behaviors and revictimization. The principal purpose of this research proposal is to evaluate the efficacy of RRFT in reducing the risk of drug abuse and other risky behaviors, PTSD, and revictimization among adolescents who have been sexually assaulted. The Research Plan will be conducted based on Stage 1a and Stage 1b from NIDA's Behavioral Therapies Development Program as described in Rounsaville, Carroll, & Onken (2001). The final phase of the research will involve conducting a pilot randomized controlled trial of RRFT in a sample of adolescents, comparing primary outcome measures of youth receiving RRFT to youth receiving usual care in the community. Participants will be adolescents (12-17 years) who have experienced a sexual assault. Assessment of substance use and other risk behaviors, trauma-related psychopathology, and incidents of revictimization will be collected at pre- and post- treatment, as well as 6-week and 3-month follow-ups. Hierarchical Linear Modeling will be the primary method used to test study hypotheses. Development and evaluation of the proposed intervention will have significant implications for addressing public health problems in adolescent substance abuse and related high risk behaviors.

Condition or disease Intervention/treatment Phase
Risk Reduction Through Family Therapy Usual Care Behavioral: Risk Reduction through Family Therapy Not Applicable

Detailed Description:
See above summary

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 135 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Risk Reduction for Drug Use and Sexual Revictimization
Actual Study Start Date : July 1, 2006
Actual Primary Completion Date : June 30, 2011
Actual Study Completion Date : June 30, 2012

Arm Intervention/treatment
Experimental: 1
RRFT
Behavioral: Risk Reduction through Family Therapy
Component based intervention based on existing empirically supported treatments
Other Name: RRFT

Active Comparator: 2
Usual care
Behavioral: Risk Reduction through Family Therapy
Component based intervention based on existing empirically supported treatments
Other Name: RRFT




Primary Outcome Measures :
  1. Time Line Follow Back and urine screen [ Time Frame: Pre and post-treatment, 3 and 6 month follow-ups ]

Secondary Outcome Measures :
  1. YRBS [ Time Frame: Pre and post-treatment, 3 and 6 month follow-ups ]
  2. FES [ Time Frame: Pre and post-treatment, 3 and 6 month follow-ups ]
  3. UCLA PTSD Reaction Index [ Time Frame: Pre, post, and 3 and 6 month follow-up ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • memorable sexual assault

Exclusion Criteria:

  • active psychosis
  • active suicidality

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00998153


Locations
United States, South Carolina
National Crime Victims Research and Treatment Center
Charleston, South Carolina, United States, 29425
Sponsors and Collaborators
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Medical University of South Carolina
ClinicalTrials.gov Identifier: NCT00998153     History of Changes
Other Study ID Numbers: K23DA018686 ( U.S. NIH Grant/Contract )
K23DA018686 ( U.S. NIH Grant/Contract )
First Posted: October 20, 2009    Key Record Dates
Last Update Posted: June 18, 2018
Last Verified: May 2018

Keywords provided by Medical University of South Carolina:
substance use
PTSD
risky behaviors
revictimization